These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function. Wang Y; Dembowsky K; Chevalier E; Stüve P; Korf-Klingebiel M; Lochner M; Napp LC; Frank H; Brinkmann E; Kanwischer A; Bauersachs J; Gyöngyösi M; Sparwasser T; Wollert KC Circulation; 2019 Apr; 139(15):1798-1812. PubMed ID: 30696265 [TBL] [Abstract][Full Text] [Related]
30. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Pitt B; Bakris G; Ruilope LM; DiCarlo L; Mukherjee R; Circulation; 2008 Oct; 118(16):1643-50. PubMed ID: 18824643 [TBL] [Abstract][Full Text] [Related]
31. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction]. Hayashi M J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031 [TBL] [Abstract][Full Text] [Related]
33. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836 [TBL] [Abstract][Full Text] [Related]
34. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129 [TBL] [Abstract][Full Text] [Related]
35. In vivo transfer of soluble TNF-alpha receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. Sugano M; Tsuchida K; Hata T; Makino N FASEB J; 2004 May; 18(7):911-3. PubMed ID: 15117889 [TBL] [Abstract][Full Text] [Related]
36. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941 [TBL] [Abstract][Full Text] [Related]
37. Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure. Cittadini A; Casaburi C; Monti MG; Di Gianni A; Serpico R; Scherillo G; Saldamarco L; Vanasia M; Saccà L Cardiovasc Drugs Ther; 2002 May; 16(3):195-201. PubMed ID: 12374896 [TBL] [Abstract][Full Text] [Related]
38. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction. Henning RJ; Shariff M; Eadula U; Alvarado F; Vasko M; Sanberg PR; Sanberg CD; Delostia V Stem Cells Dev; 2008 Dec; 17(6):1207-19. PubMed ID: 18393684 [TBL] [Abstract][Full Text] [Related]
39. Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction. Loan Le TY; Mardini M; Howell VM; Funder JW; Ashton AW; Mihailidou AS Hypertension; 2012 Jun; 59(6):1164-9. PubMed ID: 22508833 [TBL] [Abstract][Full Text] [Related]
40. Eplerenone reduced lesion size in early but not advanced atherosclerosis in apolipoprotein E-deficient mice. Raz-Pasteur A; Gamliel-Lazarovich A; Coleman R; Keidar S J Cardiovasc Pharmacol; 2012 Dec; 60(6):508-12. PubMed ID: 23232789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]